A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis
Public ClinicalTrials.gov record NCT03737851. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of elezanumab in participants with relapsing Multiple Sclerosis (RMS).
Study identification
- NCT ID
- NCT03737851
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 208 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 11, 2018 (Actual)
- Primary completion
- Aug 9, 2021 (Actual)
- Completion
- Sep 9, 2021 (Actual)
- Last update posted
- Dec 22, 2023
2018 – 2021
United States locations
- U.S. sites
- 42
- U.S. states
- 23
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham - Main /ID# 204618 | Birmingham | Alabama | 35233 | — |
| St. Josephs Hospital and Med Center /ID# 204197 | Phoenix | Arizona | 85013 | — |
| Sutter East Bay Medical Foundation-Jordon Research and Education Dev. Inst. /ID# 204249 | Berkeley | California | 94705-2017 | — |
| The Research Center of Southern California /ID# 204269 | Carlsbad | California | 92011-4213 | — |
| Vladimir Royter MD /ID# 204392 | Hanford | California | 93230-5787 | — |
| UC Irvine Health /ID# 205728 | Irvine | California | 92697 | — |
| Stanford MS Center /ID# 204283 | Palo Alto | California | 94304-1416 | — |
| UC Davis Health-Neurological Surgery /ID# 204188 | Sacramento | California | 95817-2307 | — |
| UCSF School of Medicine - Neurology /ID# 204251 | San Francisco | California | 94143-0003 | — |
| University of Colorado School of Medicine /ID# 204250 | Aurora | Colorado | 80045-2527 | — |
| Advanced Neurosciences Research, LLC /ID# 204289 | Fort Collins | Colorado | 80528 | — |
| The University of Chicago Medical Center /ID# 205319 | Chicago | Illinois | 60637-1443 | — |
| Indiana Univ School Medicine /ID# 204891 | Indianapolis | Indiana | 46202 | — |
| Rowe Neurology Institute /ID# 204391 | Lenexa | Kansas | 66214 | — |
| The NeuroMedical Center /ID# 204253 | Baton Rouge | Louisiana | 70810 | — |
| Ochsner Medical Center /ID# 204189 | New Orleans | Louisiana | 70121-2429 | — |
| Duplicate_Parexel International /ID# 204273 | Baltimore | Maryland | 21225 | — |
| International Neurorehabilitation Institute /ID# 213332 | Lutherville | Maryland | 21093-6016 | — |
| Pediatric Endocrine Associates /ID# 204279 | Boston | Massachusetts | 02114 | — |
| Michigan Institute for Neurological Disorders (MIND) /ID# 204194 | Farmington Hills | Michigan | 48334 | — |
| Memorial Neurological Institute and Center for Multiple Sclerosis /ID# 206328 | Owosso | Michigan | 48867-2116 | — |
| Ridgeview Specialty Clinic Chaska - Neurology /ID# 204383 | Chaska | Minnesota | 55318-4551 | — |
| Washington University-School of Medicine /ID# 204388 | St Louis | Missouri | 63110 | — |
| The MS Center for Innovations in Care at Missouri Baptist Medical Center /ID# 205433 | St Louis | Missouri | 63131-2322 | — |
| Cleveland Clinic Lou Ruvo Cent /ID# 204745 | Las Vegas | Nevada | 89106-0100 | — |
| Oklahoma Med Res. Foundation /ID# 204389 | Oklahoma City | Oklahoma | 73104 | — |
| Providence Neurological Specialties - West /ID# 204248 | Portland | Oregon | 97225-6646 | — |
| Thomas Jefferson University /ID# 204281 | Philadelphia | Pennsylvania | 19107 | — |
| Advanced Neurosciences Institute /ID# 204557 | Franklin | Tennessee | 37064 | — |
| KCA Neurology - Franklin /ID# 204208 | Franklin | Tennessee | 37067-5914 | — |
| Tri-State Mountain Neurology /ID# 204252 | Johnson City | Tennessee | 37604 | — |
| Neurology Consultants of Dallas - LBJ Fwy /ID# 204398 | Dallas | Texas | 75243-1188 | — |
| UT HSC Multiple Sclerosis Research Group - Houston /ID# 206418 | Houston | Texas | 77030-1501 | — |
| Dr. Bhupesh Dihenia, MD, PA /ID# 207839 | Lubbock | Texas | 79410 | — |
| Central Texas Neurology Consul /ID# 204268 | Round Rock | Texas | 78681 | — |
| Integrated Neurology Services, PLLC /ID# 204261 | Alexandria | Virginia | 22310 | — |
| Evergreen Neuroscience Institute /ID# 204203 | Kirkland | Washington | 98034-3029 | — |
| Virginia Mason Medical Center /ID# 205440 | Seattle | Washington | 98101 | — |
| Swedish MS Center /ID# 204198 | Seattle | Washington | 98122-5698 | — |
| University of Washington Medicine MS Center /ID# 205852 | Seattle | Washington | 98133-8400 | — |
| West Virginia Univ School Med /ID# 204292 | Morgantown | West Virginia | 26506 | — |
| Froedtert Memorial Lutheran Hospital /ID# 204202 | Milwaukee | Wisconsin | 53226-3522 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03737851, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2023 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03737851 live on ClinicalTrials.gov.